NCT05484622 2026-03-12Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaServierPhase 1 Active not recruiting60 enrolled
NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled